Hydromorphone use for acute pain: Misconceptions, controversies, and risks.

Area of Science:

• Pharmacology
• Emergency Medicine
• Pain Management

Background:

• Hydromorphone (HM) is a potent opioid analgesic frequently administered in emergency departments (EDs) and acute care settings.
• Recent trends show a significant rise in HM use in the ED compared to other opioids.
• HM's efficacy is established, but concerns exist regarding adverse drug events, medication errors, and abuse liability due to its euphoric effects.

Purpose of the Study:

• To review the pharmacology, dosing, efficacy, tolerability, safety, and abuse profile of hydromorphone.
• To address the uncertainties surrounding HM's contribution to opioid abuse and overdose, particularly in patients with pre-existing chronic opioid use.
• To discuss controversies and strategies for the appropriate use of hydromorphone in acute care settings.

Main Methods:

• Literature review of hydromorphone's pharmacology, clinical use, and safety data.
• Analysis of trends in hydromorphone administration in emergency departments.
• Examination of existing data on opioid analgesic use in patients with chronic opioid exposure.

Main Results:

• Hydromorphone is effective for acute pain but associated with adverse events and medication errors.
• Intravenous hydromorphone possesses significant euphoric effects, raising concerns about abuse potential.
• Limited data exist on how acute opioid administration interacts with pre-existing chronic opioid use to influence addiction.

Conclusions:

• Hydromorphone's increasing use necessitates a thorough understanding of its risks and benefits.
• Further research is needed to clarify the relationship between acute hydromorphone administration and long-term opioid abuse or overdose.
• Developing strategies for appropriate hydromorphone use is crucial to balance effective pain management with patient safety and mitigate abuse potential.